XML 26 R14.htm IDEA: XBRL DOCUMENT
v3.20.4

Note 7 - Stock-based Compensation | 9 Months Ended
--- | ---
Oct. 31, 2020
Notes to Financial Statements |
Share-based Payment Arrangement [Text Block] | Note 7 - Stock-based compensation The Company's 2017 Omnibus Stock Incentive Plan dated June 13, 2017, as amended, which the Company's stockholders approved in June 2017 ( "2017 Plan"), expired in June 2020. Prior to the 2017 Plan's expiration, grants were made to the Company's employees, officers and independent directors, as described below. The Company has prior incentive plans under which previously granted awards remain outstanding, but under which no new awards may be granted. At October 31, 2020 the Company had reserved a total of 529,570 shares for grants and issuances under these incentive stock plans, which includes a reserve for issuances pursuant to unvested or unexercised prior awards. While the 2017 Plan provided for the grant of deferred shares, non-qualified stock options, incentive stock options, restricted shares, restricted stock units, and performance-based restricted stock units intended to qualify under section 422 of the Internal Revenue Code, the Company issued only restricted shares and restricted stock units under the 2017 Plan. The 2017 Plan authorized awards to officers, employees, consultants and independent directors. The Company has granted stock-based compensation awards to eligible employees, officers or independent directors. The following were the Company's stock-based compensation expenses for the periods presented:
|  | Three Months Ended October 31, |  |  | Nine Months Ended October 31, |
|  | 2020 |  |  | 2019 |  |  | 2020 |  |  | 2019 |
Stock-based compensation expense |  | $ | - |  |  | $ | 2 |  |  | $ | 3 |  |  | $ | 10 |
Restricted stock-based compensation expense |  |  | 285 |  |  |  | 224 |  |  |  | 761 |  |  |  | 776 |
Total stock-based compensation expense |  | $ | 285 |  |  | $ | 226 |  |  | $ | 764 |  |  | $ | 786 |
Stock Options The Company did not grant any stock options during the three or nine months ended October 31, 2020 . The following tables summarizes the Company's stock option activity:
Option activity |  | No. of Shares Underlying Options |  |  | Weighted Average Exercise Price |  |  | Weighted Average Remaining Contractual Term |  |  | Aggregate Intrinsic Value |
Outstanding at January 31, 2020 |  |  | 132 |  |  | $ | 8.98 |  |  |  | 3.2 |  |  | $ | 160 |
Expired or forfeited |  |  | (18 | ) |  |  | - |  |  |  | - |  |  |  | - |
Outstanding at October 31, 2020 |  |  | 114 |  |  |  | 9.20 |  |  |  | 2.6 |  |  |  | - |
Exercisable at October 31, 2020 |  |  | 114 |  |  | $ | 9.20 |  |  |  | 2.6 |  |  | $ | - |
No stock options were exercised during the nine months ended October 31, 2020 .
Unvested option activity |  | No. of Shares Underlying Options |  |  | Weighted Average Grant Date Fair Value |  |  | Aggregate Intrinsic Value |
Outstanding at January 31, 2020 |  |  | 3 |  |  | $ | 7.33 |  |  | $ | 4 |
Vested |  |  | (3 | ) |  |  | - |  |  |  | - |
Expired or forfeited |  |  | - |  |  |  | - |  |  |  | - |
Outstanding at October 31, 2020 |  |  | - |  |  | $ | - |  |  | $ | - |
As of October 31, 2020 , there were no remaining unvested stock options outstanding, and therefore no unrecognized compensation expense related to unvested stock options. Restricted stock The following table summarizes the Company's restricted stock activity for the nine months ended October 31, 2020 :
Restricted stock activity |  | Restricted Shares |  |  | Weighted Average Grant Price Per Share |  |  | Aggregate Intrinsic Value |
Outstanding at January 31, 2020 |  |  | 321 |  |  | $ | 8.89 |  |  | $ | 2,857 |
Granted |  |  | 156 |  |  |  | 5.88 |  |  |  |  |
Vested and issued |  |  | (63 | ) |  |  | 8.96 |  |  |  |  |
Forfeited or retired for taxes |  |  | (38 | ) |  |  | 8.20 |  |  |  |  |
Outstanding at October 31, 2020 |  |  | 376 |  |  | $ | 7.61 |  |  | $ | 2,857 |
As of October 31, 2020 , there was $1.6 million of unrecognized compensation expense related to unvested restricted stock granted under the 2017 Plan. That cost is expected to be recognized over a weighted average period of 1.9 years.

X
- Definition The entire disclosure for share-based payment arrangement. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -URI http://asc.fasb.org/topic&trid=2228938 + Details
Name: | us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_DisclosureTextBlockAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration